Crystal structure of (E)-2-((2-methoxy-3-pyridyl)methylene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
Zhang Xiao-Fan,Meng Qing-Guo +1 more
Reads0
Chats0
About:
This article is published in Zeitschrift Fur Kristallographie-new Crystal Structures.The article was published on 2021-05-01 and is currently open access. It has received 4 citations till now. The article focuses on the topics: Methylene & Crystal structure.read more
Citations
More filters
Journal ArticleDOI
Crystal structure of (E)-7-methoxy-2-((5-methoxypyridin-3-yl)methylene)-3,4- dihydronaphthalen-1(2H)-one, C18H17NO3
Ming-Zhu Luan,Qing-Guo Meng +1 more
Journal ArticleDOI
Crystal structure of (3E,5E)-3,5-bis-4-methoxy-3-(trifluoromethyl)benzylidene)-1-methylpiperidin-4-one, C24H21F6NO3
TL;DR: In this article, a monoclinic P21/c (no. 14), a = 16.6493(9) Å, b = 15.3005(8)Å, c = 8.8554(5)À, β = 99.746(6)°, V = 2223.3(2)Á3, Z = 4, Rgt(F) = 0.0444, wRref(F2)= 0.1094, T = 100 K.
Journal ArticleDOI
Crystal structure of (E)-7-fluoro-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
Journal ArticleDOI
Crystal structure of E-7-fluoro-2-(2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C18H12F4O
TL;DR: In this article , the triclinic trichloric P1̄ (no. 2), a = 7.9400(8) and b = 8.1071(9) Å, c = 13.3238(15) and α = 89.394 (9 ) ° $89.394\left(9\right)^{\circ} $ , β = 76.343 ( 9 ) °$76.
References
More filters
Journal ArticleDOI
A short history of SHELX
TL;DR: This paper could serve as a general literature citation when one or more of the open-source SH ELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure determination.
Journal ArticleDOI
Crystal structure refinement with SHELXL
TL;DR: New features added to the refinement program SHELXL since 2008 are described and explained.
Journal ArticleDOI
Role of Microglia in CNS Autoimmunity
Tobias Goldmann,Marco Prinz +1 more
TL;DR: The current knowledge regarding the highly diverse and complex function of microglia during CNS autoimmunity in either promoting tissue injury or tissue repair in MS is summarized.
Journal ArticleDOI
The role of microglial activation in disease progression.
TL;DR: Modulation of microglial activation for therapeutic purposes must consider suppressing deleterious effects of these cells, while simultaneously preserving their protective functions.
Journal ArticleDOI
Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways
TL;DR: The inhibitory ability of DSF-52 on microglia- mediated neuroinflammation may offer a novel neuroprotective modality and could be potentially useful in inflammation-mediated neurodegenerative diseases.